References

• 1. Molina JR, Adjei AA, Jett JR. Advances in chemotherapy of non-small cell lung cancer. Chest 2006; 130: 1211-19. google scholar
• 2. Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker JrS, et al. American Society of Clinical Oncology treatment of unresectable non–small-cell lung cancer guideline: Update 2003. J Clin Oncol 2004; 22: 330-53. google scholar
• 3. Sosa Iglesias V, Giuranno L, Dubois LJ, Theys J, Vooijs M. Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting? Front Oncol 2018; 8: 267. google scholar
• 4. Alibeiki F, Jafari N, Karimi M, Peeri Dogaheh H. Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells. Sci Rep 2017; 7: 1-9. google scholar
• 5. Aggarwal BB, Surh YJ, Shishodia S. The molecular targets and therapeutic uses of curcumin in health and disease. 1st edition. New York : Springer Science & Business Media; 2007. google scholar
• 6. Priyadarsini KI. The chemistry of curcumin: From extraction to therapeutic agent. Molecules 2014; 19: 20091-12. google scholar
• 7. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: An “old-age” disease with an “age-old” solution. Cancer Lett 2008; 267: 133-64. google scholar
• 8. Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 2001; 47: 293-303. google scholar
• 9. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 2001; 20: 7597–7609. 10. Liu Q, Loo WTY, Sze SCW, Tong Y. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFB, cyclinD and MMP-1 transcription. Phytomedicine 2009; 16: 916-22. google scholar
• 11. Moragoda L, Jaszewski R, Majumdar AP. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res 2001; 21: 873-78. google scholar
• 12. Atmaca H, Uzunoglu S. Anti-angiogenic effects of trabectedin (Yondelis; ET-743) on human breast cancer cells. Eur Cytokine Netw 2014; 25: 1-7. google scholar
• 13. Karaca B, Kucukzeybek Y, Gorumlu G, Erten C, Gul MK, Cengiz E et al. Profiling of angiogenic cytokines produced by hormone-and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol. Eur Cytokine Netw 2008; 19:176-84. google scholar
• 14. Erten C, Karaca B, Kucukzeybek Y, Gorumlu G, Cengiz E, Gul MK, et al. Regulation of growth factors in hormone‐and drug‐resistant prostate cancer cells by synergistic combination of docetaxel and octreotide. BJU Int 2009; 104, 107-14. google scholar
• 15. Von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, et al. STRING: known and predicted protein–protein associations, integrated and transferred across organisms. Nucleic Acids Res 2005; 33: 433-37. google scholar
• 16. Scheff SW. Fundamental statistical principles for the neurobiologist: A survival guide. 1st edition. New York : Academic Press; 2016. google scholar
• 17. Boroumand N, Samarghandian S, Hashemy SI. Immunomodulatory, anti-inflammatory, and antioxidant effects of curcumin. J Herbmed Pharmacol 2018; 7: 211-19. google scholar
• 18. Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev 2009; 14: 141-53. google scholar
• 19. Hewlings SJ, Kalman DS. Curcumin: a review of its’ effects on human health. Foods 2017; 6: 92. google scholar
• 20. Tomeh MA, Hadianamrei R, Zhao X. A review of curcumin and its derivatives as anticancer agents. Int J Mol Sci 2019; 20: 1033. google scholar
• 21. Allegra A, Innao V, Russo S, Gerace D, Alonci A, Musolino C. Anticancer activity of curcumin and its analogues: preclinical and clinical studies. Cancer Invest 2017; 35: 1-22. google scholar
• 22. Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res 2015; 35: 645-51. google scholar
• 23. Mirski SE Gerlach JH, Cole SP. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res 1987; 47: 2594-98. google scholar
• 24. Li P, Qin H, Li X. The effect of curcumin on the apoptosis of lung cancer cells by regulating DJ-1-PTEN/PI3K/AKT signaling. Int J Clin Exp Med 2019; 12: 8739-45. google scholar
• 25. Yang CL, Ma YG, Xue YX, Liu YY, Xie H, Qiu GR. Curcumin induces small cell lung cancer NCI-H446 cell apoptosis via the reactive oxygen species mediated mitochondrial pathway and not the cell death receptor pathway. DNA Cell Biol 2012; 31: 139-50. google scholar
• 26. Jin H, Qiao F, Wang Y, Xu Y, Shang Y. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway. Oncol Rep 2015; 34: 2782-89. google scholar
• 27. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005; 4: 147-71. google scholar
• 28. Giam M, Huang DCS. Bouillet, P. BH3-only proteins and their roles in programmed cell death. Oncogene 2008; 27: 128-36. google scholar
• 29. Zuo L, Zhou T, Pannell BK, Ziegler AC, Best TM. Biological and physiological role of reactive oxygen species–the good, the bad and the ugly. Acta Physiol 2015; 214: 329-48. google scholar
• 30. Zhu Y, Bu S. Curcumin induces autophagy, apoptosis, and cell cycle arrest in human pancreatic cancer cells. Evid Based Complementary Altern Med 2017; 2017. google scholar
• 31. Larasati YA, Yoneda-Kato N, Nakamae I, Yokoyama T, Meiyanto E, Kato JY. Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth. Sci Rep 2018; 8: 1-13. google scholar
• 32. Chen Q, Wang Y, Xu K, Lu G, Ying Z, Wu L, et al. Curcumin induces apoptosis in human lung adenocarcinoma A549 cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Oncol Rep 2010; 23: 397-403. google scholar
• 33. Kuttikrishnan S, Siveen KS, Prabhu KS, Khan AQ, Ahmed EI, Akhtar S, et al. Curcumin induces apoptotic cell death via inhibition of PI3-Kinase/AKT pathway in B- precursor acute lymphoblastic leukemia. Front Oncol 2019:9. google scholar
• 34. Lu T, Zhu Z, Wu J, She H, Han R, Xu H, et al. DRAM1 regulates autophagy and cell proliferation via inhibition of the phosphoinositide 3-kinase-Akt-mTOR-ribosomal protein S6 pathway. Cell Commun Signal 2019; 17: 28. google scholar
• 35. Johnson SM, Gulhati P, Arrieta I, Wang X, Uchida T, Gao T, et al. Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Res 2009; 29: 3185-3190. google scholar
• 36. Shinojima N, Yokoyama T, Kondo Y, Kondo, S. Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 2007; 3: 635-637. google scholar
• 37. Moreau R, Kaur H. Curcumin and piperine inhibit mTORC1 signaling in intestinal epithelial cells. The FASEB Journal 2017; 31: 135-138. google scholar
• 38. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002; 277: 21119-22. google scholar

Citations